Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Griffen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|May 26, 1988
Prevalence of hemochromatosis among 11,065 presumably healthy blood donorsC Q Edwards, L M Griffen, D Goldgar, et al.
Journal of Medical Genetics|January 1, 1997
Recombinations defining centromeric and telomeric borders for the hereditary haemochromatosis locusR S Ajioka, P Yu, J R Gruen, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1994
Blood lead concentrations in hereditary hemochromatosisJ C Barton, M A Patton, C Q Edwards, et al.
Blood|September 1, 1995
Prevalence of heterozygotes for hemochromatosis in the white population of the United StatesC E McLaren, V R Gordeuk, A C Looker, et al.
Blood|February 26, 2000
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tardaZ J Bulaj, J D Phillips, R S Ajioka, et al.
The New England Journal of Medicine|November 23, 2000
Disease-related conditions in relatives of patients with hemochromatosisZ J Bulaj, R S Ajioka, J D Phillips, et al.
American Journal of Human Genetics|June 1, 1997
Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomesR S Ajioka, L B Jorde, J R Gruen, et al.
The Journal of Laboratory and Clinical Medicine|December 29, 2000
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tardaZ J Bulaj, M R Franklin, J D Phillips, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|May 26, 1988
Prevalence of hemochromatosis among 11,065 presumably healthy blood donorsC Q Edwards, L M Griffen, D Goldgar, et al.
Journal of Medical Genetics|January 1, 1997
Recombinations defining centromeric and telomeric borders for the hereditary haemochromatosis locusR S Ajioka, P Yu, J R Gruen, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1994
Blood lead concentrations in hereditary hemochromatosisJ C Barton, M A Patton, C Q Edwards, et al.
Blood|September 1, 1995
Prevalence of heterozygotes for hemochromatosis in the white population of the United StatesC E McLaren, V R Gordeuk, A C Looker, et al.
Blood|February 26, 2000
Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tardaZ J Bulaj, J D Phillips, R S Ajioka, et al.
The New England Journal of Medicine|November 23, 2000
Disease-related conditions in relatives of patients with hemochromatosisZ J Bulaj, R S Ajioka, J D Phillips, et al.
American Journal of Human Genetics|June 1, 1997
Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomesR S Ajioka, L B Jorde, J R Gruen, et al.
The Journal of Laboratory and Clinical Medicine|December 29, 2000
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tardaZ J Bulaj, M R Franklin, J D Phillips, et al.
Pageof 2